GSK pumps up to $800m for US manufacturing site upgrade ...
Sectors - Pharmaceutical Technology - 网曝门
Sections. Clinical Trials · Drug Manufacturers · Therapy Area · Pricing and Market Access. Latest. Matinas BioPharma mulls wind-down as antifungal therapy ...
Fraiser Kansteiner | Digital Pharma Innovation
In its biggest U.S. manufacturing investment yet, GSK is spending up to $800 million to double the size and capacity of its site in Marietta, PA. Fraiser ...
All news articles for July 2024 - biopharma-reporter.com
BeiGene new flagship biologics manufacturing facility opens after $800M investment ... Novo Nordisk has revealed plans for a $4.1 billion investment in a new ...
Manufacturing Dive (@ManufactureDive) / X
GSK is investing $800 million to expand its Marietta, Pennsylvania, vaccine drug facility. GSK to invest $800M in Pennsylvania drug expansion · From ...
COVID-19 Health System Overload Forecaster, by Craig - Swellnet
... $800m New Plant goin' up (Across from Urbnsurf) Gates has a long time Plasma deal with CSL + is kicking in half for Cell based FluceVax upgrade. Plant should ...